The size of the North American Clinical Nutrition market was worth USD 4.57 Billion in 2020 and estimated to be growing at a CAGR of 4.76% to reach USD 5.76 Billion by 2025. North America is the third-largest market for clinical nutrition products.
Clinical nutrition is an area of medicine that offers treatment of medical disorders initiated due to improper diet or due to the body’s failure to absorb nutrients accessible in a healthy diet. It is the most effective way to treat malnutrition and avoid associated costs. These products are considered to be the best alternatives for the treatment of different diseases, such as kidney diseases, diabetes, cardiovascular diseases, and cancer.
Clinical nutrition spends are expected to increase due to the rise in the aged population. At old age, the digestive framework becomes weak and is unable to digest all the required minerals by the body. Therefore to get adequate supplements, the assurance of the aged population towards clinical nutrition support is developing.
The restraints allied with the clinical nutrition market include stringent regulations and lack of awareness.
This research report segmented and sub-segmented into the following categories:
Regional Analysis
In 2019, the United States Clinical Nutrition Market dominated the North America region. Growing consumer awareness about proper health and wellbeing is driving the market in this region.
Growing geriatric population base, the growing burden of chronic diseases such as coronary artery disease, ischemic stroke, diabetes, few cancer indications are driving the growth of the U.S. clinical nutrition market. Moreover, the demand for medical nutrition therapy has increased due to the rising prevalence of diabetes in the United States. According to the report by the International Diabetes Federation 2018, there are 34.2 million or 10.5% of the total population suffer from diabetics. It is anticipated to raise the demand for medical nutrition therapy for diabetes as well, which will propel the growth of the U.S. clinical nutrition market.
The Canadian market for clinical nutrition is increasing due to a tremendous birth rate, rising no. of malnutrition patients receiving treatment, and a larger no. of premature births. Besides, increasing prevalence of chronic disorders and an increase in the number of patients using advanced clinical nutritional products increases the market growth. The initiative was taken by the Canadian government authority to promote complete nutrition care is favoring the market. Increase in metabolic disorders, high disposable incomes, and improvement in patient awareness regarding the adoption of clinical nutrition products expected to drive the Canadian clinical nutrition market further.
Companies playing a dominant role in the North America Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Route of Administration
5.1.1 Oral Nutrition
5.1.2 Enteral Nutrition
5.1.3 Parenteral Nutrition
5.2 By Therapeutic Area
5.2.1 Malabsorption
5.2.2 Diarrhoea
5.2.3 Cancer
5.2.4 Food Allergies
5.2.5 Maldigestion
5.2.6 Diabetes
5.2.7 Short-Bowel Syndrome
5.2.8 Acute Lung Injury
5.2.9 Acute Respiratory Distress
5.3 By Ingredients Type
5.3.1 Vitamins
5.3.2 Minerals
5.3.3 Carbohydrates
5.3.4 Amino Acids
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Nestle Nutrition
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories Inc.
8.3 Gentiva Health Services Inc.
8.4 Mead Johnson & Company
8.5 Kendall
8.6 Ajinomoto Co. Inc.
8.7 Hospira Inc.
8.8 Hero Nutritionals Inc.
8.9 Lonza Ltd
8.10 Baxter International Inc.
8.11 B. Braun Melsungen AG
8.12 H. J. Heinz Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
